Rising Interest Rates Weigh on Small-Cap Stocks

Image courtesy of Fast Company

Small-cap stocks face pressure as rising interest rates challenge Trump’s pro-growth agenda. Investors weigh potential gains against the reality of increased borrowing costs.

In the financial realm, where expectations often dance with reality, small-cap stocks have recently found themselves caught in an intricate tango of market forces.

Once the darlings of investors betting on a Donald Trump presidency, these smaller U.S. companies are now grappling with a formidable adversary: the rising tide of interest rates.

This tumultuous environment has left the small-cap Russell 2000 index, which once soared in the post-election euphoria, marking a sobering 10% correction from its November highs.

The allure of small caps was undeniable.

Trump’s pro-growth agenda, with its promise of domestic economic invigorations, seemed a tailor-made boon for these smaller enterprises, whose operations are often more U.S.-centric compared to their multinational counterparts.

Yet, like an unwelcome guest at a celebration, the specter of higher borrowing costs looms large, casting a shadow over their potential gains.

Keith Lerner, co-chief investment officer at Truist Advisory Services, poignantly described this situation as a “tug of war.”

On one side, the prospect of stronger growth could propel small caps into a renaissance.

On the other, the harsh reality of climbing interest rates threatens to erode their very foundation.

The recent calming of surging Treasury yields, thanks to an encouraging inflation report, provided a temporary reprieve, but the underlying tension remains palpable.

Investors seeking the elusive “Trump trades” are left pondering their next moves.

While shares of companies like Tesla, buoyed by Elon Musk’s staunch support of Trump, and the cryptocurrency Bitcoin have thrived, small caps have not followed suit.

The Russell 2000 had its moment of glory, surging nearly 6% post-election, reaching heights not seen in three years.

However, this initial burst of optimism has since fizzled, leaving the index largely unchanged.

The Federal Reserve’s December decision to project fewer interest rate cuts has not helped matters.

With the benchmark 10-year yield recently hitting a 14-month high, the pressure on small caps has intensified.

Yung-Yu Ma of BMO Wealth Management encapsulated the sentiment aptly: smaller companies, burdened with more significant debt loads, are in dire need of lower interest rates to sustain their momentum.

Yet, this expectation seems increasingly out of reach.

Historically, the Trump era has been kind to the Russell 2000.

Following his 2016 election, the index outperformed its large-cap counterpart, the S&P 500, showcasing a 24% rise compared to a 21% gain for the latter.

The promise of reduced regulations and a focus on bolstering domestic enterprises offered a fertile ground for small caps to flourish.

However, Trump’s favoring of tariffs could pose a double-edged sword, potentially disrupting supply chains critical to these companies’ operations.

In the grand tapestry of market dynamics, small-cap bulls are banking on a much-needed resurgence to bridge the yawning gap with the S&P 500, which has enjoyed nearly a 50% rise over the past two years.

Yet, as Lerner of Truist suggests, the fate of small caps is inextricably linked to the interest rate environment.

Their heavy weighting towards financials and industrials, sectors notoriously sensitive to rate hikes, places them in a precarious position should rates continue their upward march.

As the curtain rises on Trump’s second term, the road ahead for small caps is fraught with both opportunity and peril.

The delicate balance between a favorable policy environment and the harsh realities of rising interest rates will undoubtedly shape their narrative.

For now, investors must navigate these choppy waters with cautious optimism, ever mindful of the market’s capricious nature.

The Checkup

A weekly newsletter focusing on the most important news in health and biotech.

More News

At Global Business & Economics Journal, we contribute to the  future of business and technology with news,  innovative research, expert insights, and thought-provoking analysis.

The latest from
The Checkup: Our weekly biotech and health email

Sign up to get The Checkup weekly in your inbox.